These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17428235)

  • 1. Adenosine is not a direct GHSR agonist--artificial cross-talk between GHSR and adenosine receptor pathways.
    Hermansson NO; Morgan DG; Drmota T; Larsson N
    Acta Physiol (Oxf); 2007 May; 190(1):77-86. PubMed ID: 17428235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells.
    Ryzhov S; Goldstein AE; Biaggioni I; Feoktistov I
    Mol Pharmacol; 2006 Aug; 70(2):727-35. PubMed ID: 16707627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence against adenosine analogues being agonists at the growth hormone secretagogue receptor.
    Johansson S; Fredholm BB; Hjort C; Morein T; Kull B; Hu PS
    Biochem Pharmacol; 2005 Aug; 70(4):598-605. PubMed ID: 15979585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
    Mouawad R; Li Y; Anand-Srivastava MB
    Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction mechanism of the seabream growth hormone secretagogue receptor.
    Chan CB; Leung PK; Wise H; Cheng CH
    FEBS Lett; 2004 Nov; 577(1-2):147-53. PubMed ID: 15527776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-specific coupling of growth hormone secretagogue receptor type 1a to different intracellular signaling systems. Role of adenosine.
    Carreira MC; Camiña JP; Smith RG; Casanueva FF
    Neuroendocrinology; 2004 Jan; 79(1):13-25. PubMed ID: 14755130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.
    Varani K; Gessi S; Merighi S; Vincenzi F; Cattabriga E; Benini A; Klotz KN; Baraldi PG; Tabrizi MA; Lennan SM; Leung E; Borea PA
    Biochem Pharmacol; 2005 Nov; 70(11):1601-12. PubMed ID: 16219300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine does not bind to the growth hormone secretagogue receptor type-1a (GHS-R1a).
    Carreira MC; Camiña JP; Díaz-Rodríguez E; Alvear-Perez R; Llorens-Cortes C; Casanueva FF
    J Endocrinol; 2006 Oct; 191(1):147-57. PubMed ID: 17065398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
    Lin CW; Miller TR; Witte DG; Bianchi BR; Stashko M; Manelli AM; Frail DE
    Mol Pharmacol; 1995 Jan; 47(1):131-9. PubMed ID: 7838121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20.
    Gessi S; Varani K; Merighi S; Cattabriga E; Pancaldi C; Szabadkai Y; Rizzuto R; Klotz KN; Leung E; Mac Lennan S; Baraldi PG; Borea PA
    Mol Pharmacol; 2005 Jun; 67(6):2137-47. PubMed ID: 15788741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
    Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.
    Linden J; Thai T; Figler H; Jin X; Robeva AS
    Mol Pharmacol; 1999 Oct; 56(4):705-13. PubMed ID: 10496952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake.
    Töpfer M; Burbiel CE; Müller CE; Knittel J; Verspohl EJ
    Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5'-N-ethylcarboxamide induces IL-6 expression via MAPKs and NF-kappaB activation through Akt, Ca(2+)/PKC, cAMP signaling pathways in mouse embryonic stem cells.
    Kim MO; Kim MH; Lee SH; Suh HN; Lee YJ; Lee MY; Han HJ
    J Cell Physiol; 2009 Jun; 219(3):752-9. PubMed ID: 19194991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone-induced calcium release from intracellular stores in a human kidney cell line in the absence of stimulation of cyclic adenosine 3',5'-monophosphate production.
    Jobert AS; Leroy C; Butlen D; Silve C
    Endocrinology; 1997 Dec; 138(12):5282-92. PubMed ID: 9389512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between adenosine A 2B-receptors and alpha2-adrenoceptors on the modulation of noradrenaline release in the rat vas deferens: possible involvement of a group 2 adenylyl cyclase isoform.
    Talaia C; Queiroz G; Quintas C; Gonçalves J
    Neurochem Int; 2005 Nov; 47(6):418-29. PubMed ID: 16040158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine induces cyclic-AMP formation and inhibits endothelin-1 production/secretion in guinea-pig tracheal epithelial cells through A(2B) adenosine receptors.
    Pelletier S; Dubé J; Villeneuve A; Gobeil F; Bernier SG; Battistini B; Guillemette G; Sirois P
    Br J Pharmacol; 2000 Jan; 129(2):243-50. PubMed ID: 10694229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium mobilization in Jurkat cells via A2b adenosine receptors.
    Mirabet M; Mallol J; Lluis C; Franco R
    Br J Pharmacol; 1997 Nov; 122(6):1075-82. PubMed ID: 9401772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four missense mutations in the ghrelin receptor result in distinct pharmacological abnormalities.
    Liu G; Fortin JP; Beinborn M; Kopin AS
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1036-43. PubMed ID: 17596538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel adenosine and cAMP signalling pathways in migrating glial cells.
    Bernascone S; Erriquez J; Ferraro M; Genazzani AA; Distasi C
    Cell Calcium; 2010 Jul; 48(1):83-90. PubMed ID: 20688392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.